HC Wainwright cuts Moleculin Biotech price target to $3
HC Wainwright & Co. cut its Moleculin Biotech price target to $3.00/share from $22.00/share.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.